Back to Home

Drug Pricing & Affordability

Expert articles and analysis related to drug pricing & affordability.

200 articlesLast 7 Days

AI Summary — Last 7 Days

No recent expert commentary on Drug Pricing & Affordability in the last 7d.

Related Articles

98ALN

MFP Effectuation and the SDRA: The Possibility of ASP Spirals in Competitive Drug Classes[

AvalereAug 17, 2026
95ALN

Federal appeals court revives part of Teva's IRA case as Austedo price cuts loom

After a lower court rejected Teva's case last fall, a federal appeals court has revived part of the drugmaker’s lawsuit against Medicare negotiations. The DC Circuit Court ruled on Tuesday that Teva...

Endpoints NewsAug 19, 2026
95ALN

Response to Senate Finance Committee request for information on policies for lowering drug prices

Response to Senate Finance Committee request for information on policies for lowering drug prices  Brookings

BrookingsAug 18, 2026
95ALN

Comments on the Medicare Drug Price Negotiation Program proposed rule for IPAY 2029

Comments on the Medicare Drug Price Negotiation Program proposed rule for IPAY 2029  Brookings

BrookingsAug 18, 2026
95ALN

Legislative Proposals Aim to Modify the 340B Program

AvalereAug 18, 2026
95ALN

STAT+: The White House declares ‘promises made, promises kept’ on lowering drug prices. Nice try

In its effort to lower drug prices, the White House has declared "promises made, promises kept." That's a narrative that doesn't reflect the full story.

STAT NewsAug 18, 2026
95ALN

Trump is taking credit for lower list prices. But a Biden-era law did a lot of the heavy lifting

List prices for brand-name drugs have declined significantly in 2026. But the reasons behind it may have more to do with a Biden-era law than any of the Trump administration's recent initiatives, expe...

Endpoints NewsAug 18, 2026
95ALN

Businesses increase support for hospital price caps

Business groups increasingly support various approaches to cap hospital prices. Although many business groups continue their traditional opposition to any government price controls, an increasing numb...

HFMAAug 18, 2026
95ALN

AHA comments on CMS proposal to codify Medicare Drug Price Negotiation Program regulations

AHA comments on CMS proposal to codify Medicare Drug Price Negotiation Program regulations  American Hospital Association

AHAAug 17, 2026
95ALN

A recent historic drop in drug prices is largely driven by market forces, Joyce explains

The post A recent historic drop in drug prices is largely driven by market forces, Joyce explains appeared first on USC Schaeffer.

USC SchaefferAug 17, 2026